Bacillus anthracis and antibacterial agents

Clinical Microbiology and Infection

Volumn 8, Issue 8, 2002, Pages 467-478

  Bryskier, A ^a  

^a SANOFI   (France)

Author keywords

Anthrax; Antibiotics; Doxycycline; Fluoroquinolones; Ketolides; Macrolides; lactams

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTHRAX TOXIN; ANTIBIOTIC AGENT; CEFACLOR; CEFALEXIN; CEFAZOLIN; CEFDINIR; CEFDITOREN; CEFETAMET; CEFIXIME; CEFMENOXIME; CEFOPERAZONE; CEFOTAXIME; CEFOTIAM; CEFPIMIZOLE; CEFPODOXIME; CEFTERAM; CEFTIBUTEN; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; DOXYCYCLINE; KETOLIDE; MACROLIDE; PENICILLIN G; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULBENICILLIN; UNINDEXED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHRAX; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACILLUS ANTHRACIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ACTIVITY; DRUG DISTRIBUTION; DRUG POTENCY; ENDEMIC DISEASE; EXPERIMENTAL MODEL; FEMALE; GASTROINTESTINAL INFECTION; GUINEA PIG; HUMAN; IN VITRO STUDY; INTOXICATION; LUNG INFECTION; LYMPH NODE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; THREAT;

ANIMALIA; ANTHRAX; BACILLUS ANTHRACIS; CAVIA PORCELLUS; SUS SCROFA;

EID: 0036670994     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2002.00527.x     Document Type: Review

References (83)

1. Virgil on anthrax
2. Inoculation de sang de rate
3. Mikroskopische und Mikrochemische unterschungen des Milbrandlute sowie über wesen und kur des Milzbrandes
4. Recherches sur les infusoires du sang dans la maladie connue sur le nom de sang de rate
5. Recherches sur les infusoires du sang dans la maladie connue sur le nom de sang de rate
6. Die Ätiologie der Milbrandkrankheit, begrüdet die Entwicklunsgesicht des Bacillus Anthracis
7. The legacy of Robert Koch
8. Lectures on some recent investigations into the pathology of infective and contagious diseases. Lecture III.-Part I. Anthrax and anthracoid diseases
9. Compte rendu sommaire des expériences faîtes á Pouilly-le Fort près de Melun, sur la vaccination charbonneuse
10. Anthrax: A disease from antiquity visits the modern world
11. Bacillus anthracis
12. Anthrax
13. Transmission of anthrax
14. On anthrax and anthracemia in wool, heifers, and sheep
15. Anthrax: An overview within the Indian subcontinent
16. Anthrax in Zimbabwe
17. Evaluation of serologic tests for diagnosis of anthrax after an outbreak of cutaneous anthrax in Paraguay
18. Molecular characterization of Bacillus strains involved in outbreaks of anthrax in France in 1997
19. The Sverdlovsk anthrax outbreak of 1979
20. Anthrax upon man
21. Eine milzbrandepidernie in der Schweiz
22. Familial outbreak of agriculture anthrax in an area of Northern Italy
23. Une épidémie de charbon humain-à propos de 25 cas observés à l'hôpital de Fort-Lamy, Tchad
24. Anthrax
25. Outbreak of anthrax in Thailand
26. Anthrax pneumonia
27. Cutaneous anthrax acquired from imported Haitiean drums-Florida
28. Human anthrax with epizootic among livestock-North-Dakota
29. Biological warfare: A historical perspective
30. Factories of death: Japanese secret biological warfare, 1932-45, and the American cover-up
31. The decontamination of Gruinard Island
32. Avirulent anthrax vaccine
33. Determination of Bacillus anthracis antibiotic susceptibility by broth microdilution
34. In vitro activity of oritavancin (LY333328), levofloxacin, meropenem, GAR 936 and linezolid against strains of Bacillus anthracis
35. Antimicrobial testing of Bacillus anthracis: Comparison of results obtained by using the National Committee for clinical laboratory standards broth microdilution reference and E test agar gradient diffusion methods
36. Antimicrobial susceptibility of Bacillus anthracis
37. Antimicrobial susceptibility of Bacillus anthracis
38. Combined action of rifampicin and peptidoglycan in experimental anthracic infection
39. In vitro activity of ABT-773, a novel ketolide, and other antibacterials against Bacillus anthracis
40. Characterization of a rifampicin-resistant population of Bacillus anthracis
41. Molecular analysis of rifampin resistance in Bacillus anthracis and Bacillus cereus
42. Mutations of bacteria from virus sensitivity to virus resistance
43. In vitro development of resistance to ofloxacin and doxycycline in Bacillus anthracis
44. In vitro resistance of Bacillus anthracis Sterne to doxycycline, macrolides, and quinolones
45. Comparison of therapeutic effects of antibiotics of the tetracycline group in the treatment of anthrax caused by a strain inheriting tet-gene of plasmid pBC16
46. Interaction of Bacillus anthracis with benzylpenicillin in vitro and in vivo
47. Penicillin resistance in Bacillus anthracis
48. Cutaneous anthrax due to penicillin resistant Bacillus anthracis transmitted by an insect bite
49. In vitro susceptibility of Bacillus spp to selected antimicrobial agent
50. Purification and properties of penicillinase from two strains of Bacillus licheniformis: Physicochemical and physiological comparison
51. Cephalosporinase and penicillinase activity of Bacillus cereus
52. Antibiotic susceptibility profiles and β-lactamase activity in strains of Bacillus anthracis
53. Antibiotic sensitivity testing: Report of an international collaborative study
54. The antibiotic sensitivity patterns of Bacillus anthracis isolated from the Kruger National Park
55. Comparative evaluation of the effectiveness of fluoroquinolones in experimental anthrax infection
56. Antibiotic prophylaxis for inhalation anthrax
57. 60Co-irradiated mice
58. The pathogenesis of anthrax following the administration of spores by the respiratory route
59. Role of the lymphatic in the pathogenesis of anthrax
60. Penicillin and Bacillus anthracis
61. Susceptibility of irradiated mice to Bacillus anthracis Sterne by the intratracheal route of infection
62. Serum concentration of penicillin, doxycycline and ciprofloxacin during prolonged therapy in rhesus monkeys
63. Interference of antibacterial agents with phagocytes functions: Immuno modulation or 'immuno-fairy tales'
64. Traitement des fièvres typhoides par ofloxacine-expérience clinique et détermination de la diffusion ganglionnaire mésentérique de l'antibiotique
65. Assay of skin level and clinical investigation of levofloxacin in the treatment of skin infections
66. Determination of pefloxacin concentration in mesenteric lymph nodes by high-performance chromatography
67. Extravascular penetration of ciprofloxacin-A review
68. Pharmacokinetic profile: Fleroxacin
69. Azithromycin pharmacokinetics and penetration to lymph
70. Relationships between the concentrations of doxycycline in serum and in thoracic duct lymph after oral and intravenous administration in man
71. Anthrax
72. Post exposure prophylaxis against experimental inhalation anthrax
73. Penicillin therapy of human cutaneous anthrax
74. Pathogenesis of inhalation anthrax
75. Germination of Bacillus anthracis spores within alveolar macrophages
76. Pathology of inhalation anthrax in 42 cases from Sverlosk outbreak of 1979
77. Bioterrorism alleging use of anthrax and interim guidelines for management-United States
78. Pathology of experimental inhalation anthrax in the rhesus monkey
79. Clinical recognition and management of patients exposed to biological warfare agents
80. Observation on prophylaxis of experimental pulmonary anthrax in the monkey
81. Up-date: Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis
82. Update: Adverse events associated with anthrax prophylaxis among postal employees-New Jersey, New York City and the district of Columbia Metropolitan Area, 2001
83. Anthrax